CSF2 and neoplasm: In addition, the ICP34.5 gene has been replaced with a cassette encoding human GM-CSF to facilitate priming of an anti-tumor immune response,3 and an initial clinical report has confirmed that the virus can convert an immunologically suppressive “cold” tumor microenvironment (TME) into an immune-activating “hot” milieu.4